These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8379023)

  • 1. Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma.
    Pound CR; Partin AW; Epstein JI; Simons JW; Marshall FF
    Urology; 1993 Sep; 42(3):243-8. PubMed ID: 8379023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma.
    Carducci MA; Piantadosi S; Pound CR; Epstein JI; Simons JW; Marshall FF; Partin AW
    Urology; 1999 Jan; 53(1):44-9. PubMed ID: 9886586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent diffusion coefficient: An associative factor for recurrence after nephrectomy in localized renal cell carcinoma.
    Nishie A; Kakihara D; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Morita K; Kubo Y; Inokuchi J; Honda H
    J Magn Reson Imaging; 2016 Jan; 43(1):166-72. PubMed ID: 26082268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of recurrence after radical surgery for nonmetastatic renal cell carcinoma.
    Ishimura T; Sakai I; Harada K; Hara I; Eto H; Miyake H
    Int J Clin Oncol; 2004 Oct; 9(5):369-72. PubMed ID: 15549586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear morphometric analysis of metastasis in Wilms' tumor after multimodal therapy: comparison with primary tumor.
    Gearhart JP; Willmann JR; Beckwith JB; Epstein J; Partin AW
    Urology; 1995 Jan; 45(1):119-23. PubMed ID: 7817463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding?
    Rouach Y; Delongchamps N; Timsit MO; Verkarre V; Fontaine E; Peyromaure M; Mejean A
    BJU Int; 2010 Mar; 105(5):616-9. PubMed ID: 19681891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
    Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
    Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective nuclear morphometry as a prognostic factor of survival in renal cell carcinoma.
    Monge JM; Val-Bernal JF; Buelta L; GarcĂ­a-Castrillo L; Asensio L
    Histol Histopathol; 1999 Jan; 14(1):119-23. PubMed ID: 9987656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
    Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
    Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the intact specimen after laparoscopic radical nephrectomy for clinically localized renal cell carcinoma identifies a subset of patients at increased risk for recurrence.
    Cohen DD; Matin SF; Steinberg JR; Zagone R; Wood CG
    J Urol; 2005 May; 173(5):1487-90; discussion 1490-1. PubMed ID: 15821465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
    Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
    Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
    BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3N0M0 renal cell carcinoma.
    Jeon SH; Chang SG; Kim JI
    Anticancer Res; 1999; 19(6C):5593-7. PubMed ID: 10697624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy for high-risk renal cell carcinoma patients.
    Kunkle DA; Haas NB; Uzzo RG
    Curr Urol Rep; 2007 Jan; 8(1):19-30. PubMed ID: 17239313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.
    Shvarts O; Seligson D; Lam J; Shi T; Horvath S; Figlin R; Belldegrun A; Pantuck AJ
    J Urol; 2005 Mar; 173(3):725-8. PubMed ID: 15711252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
    Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
    Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.